These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 7554050

  • 21. Interlaboratory comparison of antisera and immunoassays for benzo[a]pyrene-diol-epoxide-I-modified DNA.
    Santella RM, Weston A, Perera FP, Trivers GT, Harris CC, Young TL, Nguyen D, Lee BM, Poirier MC.
    Carcinogenesis; 1988 Jul; 9(7):1265-9. PubMed ID: 3133129
    [Abstract] [Full Text] [Related]

  • 22. Effect of nuclear environment on the distribution of benzo[a]pyrene diol epoxide-induced adducts in the HPRT gene of human fibroblasts.
    Wei D, Maher VM, McCormick JJ.
    Carcinogenesis; 1996 Dec; 17(12):2695-701. PubMed ID: 9006108
    [Abstract] [Full Text] [Related]

  • 23. Immunoaffinity chromatography of carcinogen DNA adducts with polyclonal antibodies directed against benzo[a]pyrene diol-epoxide-DNA.
    Tierney B, Benson A, Garner RC.
    J Natl Cancer Inst; 1986 Jul; 77(1):261-7. PubMed ID: 3459918
    [Abstract] [Full Text] [Related]

  • 24. Identification and quantitative detection of isomeric benzo[a]pyrene diolepoxide--DNA adducts by low-temperature conventional fluorescence methods.
    Zhao R, Liu TM, Kim SK, MacLeod MC, Geacintov NE.
    Carcinogenesis; 1992 Oct; 13(10):1817-24. PubMed ID: 1423840
    [Abstract] [Full Text] [Related]

  • 25. Base pair conformation-dependent excision of benzo[a]pyrene diol epoxide-guanine adducts by human nucleotide excision repair enzymes.
    Hess MT, Gunz D, Luneva N, Geacintov NE, Naegeli H.
    Mol Cell Biol; 1997 Dec; 17(12):7069-76. PubMed ID: 9372938
    [Abstract] [Full Text] [Related]

  • 26. Relationship between adduct formation, rates of excision repair and the cytotoxic and mutagenic effects of structurally-related polycyclic aromatic carcinogens.
    McGregor WG, Wei D, Chen RH, Maher VM, McCormick JJ.
    Mutat Res; 1997 May 12; 376(1-2):143-52. PubMed ID: 9202750
    [Abstract] [Full Text] [Related]

  • 27. TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.
    Kucab JE, van Steeg H, Luijten M, Schmeiser HH, White PA, Phillips DH, Arlt VM.
    Mutat Res; 2015 Mar 12; 773():48-62. PubMed ID: 25847421
    [Abstract] [Full Text] [Related]

  • 28. ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes.
    Lu X, Liu Y, Yu T, Xiao S, Bao X, Pan L, Zhu G, Cai Y, Liu Q, Jin C, Yang J, Wu S, An L, van der Straaten T.
    PLoS One; 2013 Mar 12; 8(4):e60006. PubMed ID: 23593158
    [Abstract] [Full Text] [Related]

  • 29. Plastic antibody for DNA damage: fluorescent imaging of BPDE-dG adducts in genomic DNA.
    Yin J, Wang Z, Song M, Zhao C, Wang H.
    Analyst; 2013 Sep 07; 138(17):4958-66. PubMed ID: 23817464
    [Abstract] [Full Text] [Related]

  • 30. Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents.
    Smith WA, Gupta RC.
    Carcinogenesis; 1996 Jun 07; 17(6):1285-90. PubMed ID: 8681444
    [Abstract] [Full Text] [Related]

  • 31. p53 controls global nucleotide excision repair of low levels of structurally diverse benzo(g)chrysene-DNA adducts in human fibroblasts.
    Lloyd DR, Hanawalt PC.
    Cancer Res; 2002 Sep 15; 62(18):5288-94. PubMed ID: 12234998
    [Abstract] [Full Text] [Related]

  • 32. Differential efficiency of mutagenesis at three genetic loci in CHO cells by a benzo[a]pyrene diol epoxide.
    MacLeod MC, Adair G, Humphrey RM.
    Mutat Res; 1988 May 15; 199(1):243-54. PubMed ID: 3129654
    [Abstract] [Full Text] [Related]

  • 33. Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer.
    Feng Z, Hu W, Chen JX, Pao A, Li H, Rom W, Hung MC, Tang MS.
    J Natl Cancer Inst; 2002 Oct 16; 94(20):1527-36. PubMed ID: 12381705
    [Abstract] [Full Text] [Related]

  • 34. Immunocytochemical visualization of DNA adducts in mouse tissues and human white blood cells following treatment with benzo[a]pyrene or its diol epoxide. A quantitative approach.
    van Schooten FJ, Hillebrand MJ, Scherer E, den Engelse L, Kriek E.
    Carcinogenesis; 1991 Mar 16; 12(3):427-33. PubMed ID: 1901249
    [Abstract] [Full Text] [Related]

  • 35. A comparative investigation of DNA adducts, DNA strand breaks and gene mutations induced by benzo[a]pyrene and (+/-)-anti-benzo[a]pyrene-7,8-diol 9,10-oxide in cultured human cells.
    Hanelt S, Helbig R, Hartmann A, Lang M, Seidel A, Speit G.
    Mutat Res; 1997 Apr 24; 390(1-2):179-88. PubMed ID: 9150767
    [Abstract] [Full Text] [Related]

  • 36. The nucleotide excision repair protein XPC is essential for bulky DNA adducts to promote interleukin-6 expression via the activation of p38-SAPK.
    Schreck I, Grico N, Hansjosten I, Marquardt C, Bormann S, Seidel A, Kvietkova DL, Pieniazek D, Segerbäck D, Diabaté S, van der Horst GT, Oesch-Bartlomowicz B, Oesch F, Weiss C.
    Oncogene; 2016 Feb 18; 35(7):908-18. PubMed ID: 25982271
    [Abstract] [Full Text] [Related]

  • 37. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
    Ginsberg GL, Atherholt TB.
    Cancer Res; 1990 Feb 15; 50(4):1189-94. PubMed ID: 2105163
    [Abstract] [Full Text] [Related]

  • 38. PARP1 protects from benzo[a]pyrene diol epoxide-induced replication stress and mutagenicity.
    Fischer JMF, Zubel T, Jander K, Fix J, Trussina IREA, Gebhard D, Bergemann J, Bürkle A, Mangerich A.
    Arch Toxicol; 2018 Mar 15; 92(3):1323-1340. PubMed ID: 29196784
    [Abstract] [Full Text] [Related]

  • 39. Flow cytometric measurement of benzo[a]pyrene-diol-epoxide-DNA adducts in normal human peripheral lymphocytes and cultured human lung cancer cells.
    Shinozaki R, Inoue S, Choi KS.
    Cytometry; 1998 Apr 01; 31(4):300-6. PubMed ID: 9551606
    [Abstract] [Full Text] [Related]

  • 40. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers.
    Denissenko MF, Pao A, Pfeifer GP, Tang M.
    Oncogene; 1998 Mar 12; 16(10):1241-7. PubMed ID: 9546425
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.